C21 shows promise against COVID-19 where other drugs have failed
Report on the ATTRACT study
Idiopathic Pulmonary Fibrosis (IPF) – weathering the pandemic
Patient insights to shape development of a dCBT for IPF patients
Vicore’s ATTRACT study shows promise for novel drug C21 against COVID-19 in hospitalised patients